Morepen Laboratories hit a 20% upper circuit at ₹69.21 after reporting its strongest-ever quarterly earnings — net profit surged 4x to ₹56.4 Cr on record revenue of ₹570.1 Cr, up 34% YoY, driven by CDMO commercialization and a 42% jump in API exports.
Marico delivered a clean beat with profit jumping 25% to ₹630 Cr and revenue up 9% to ₹3,657 Cr, while EBITDA margins expanded to 20.7% — a strong signal that FMCG input cost pressures are...
